BIOMAT Database Logo BIOMAT Database Logo

[Long-term prognosis of coronary artery disease with atrial fibrillation after percutaneous coronary intervention]. 2018

H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Department of Cardiology , Fuwai Hospital and Cardiovascular Institute, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

Objective: To investigate the long-term prognosis of coronary artery disease with atrial fibrillation (AF) after percutaneous coronary intervention (PCI). Methods: A total of 10 724 patients with PCI were enrolled in 2013, and 2-year clinical outcomes in patients with AF (AF group) and without AF (non-AF group) were compared. Results: A total of 113 patients were with AF (1.1%), and 8 out of them were on triple antithrombotic therapy (9.5%), and AF group patients were with more complications. The 2-year follow-up results showed that the all-cause mortality in AF group was significantly higher than that in non-AF group (9.7% vs 1.1%; P<0.001). The incidence of cardiac death, stent thrombosis and stroke was also significantly higher in patients with AF. The incidence of major adverse cardiac and cerebrovascular events (MACCE) was also significantly higher in AF group compared with non-AF group (17.7% vs 8.8%; P<0.001), whereas the incidence of revascularization was significantly lower in the AF group than in the non-AF group (2.7% vs 8.7%; P=0.023). The incidence of myocardial infarction and bleeding had no significant difference between the two groups, and the adverse events between the two groups had no significant difference after propensity score (PS) either. Conclusions: The 2-year clinical follow-up of single-center, large-sample PCI patients shows poor prognosis in patients with AF compared with the non-AF patients. But there is no difference in the prognosis between the two groups after PS, however, this conclusion still needs to be confirmed by randomized controlled studies.

UI MeSH Term Description Entries
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001281 Atrial Fibrillation Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. Auricular Fibrillation,Familial Atrial Fibrillation,Paroxysmal Atrial Fibrillation,Persistent Atrial Fibrillation,Atrial Fibrillation, Familial,Atrial Fibrillation, Paroxysmal,Atrial Fibrillation, Persistent,Atrial Fibrillations,Atrial Fibrillations, Familial,Atrial Fibrillations, Paroxysmal,Atrial Fibrillations, Persistent,Auricular Fibrillations,Familial Atrial Fibrillations,Fibrillation, Atrial,Fibrillation, Auricular,Fibrillation, Familial Atrial,Fibrillation, Paroxysmal Atrial,Fibrillation, Persistent Atrial,Fibrillations, Atrial,Fibrillations, Auricular,Fibrillations, Familial Atrial,Fibrillations, Paroxysmal Atrial,Fibrillations, Persistent Atrial,Paroxysmal Atrial Fibrillations,Persistent Atrial Fibrillations
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D062645 Percutaneous Coronary Intervention A family of percutaneous techniques that are used to manage CORONARY OCCLUSION, including standard balloon angioplasty (PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY), the placement of intracoronary STENTS, and atheroablative technologies (e.g., ATHERECTOMY; ENDARTERECTOMY; THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL LASER ANGIOPLASTY). PTCA was the dominant form of PCI, before the widespread use of stenting. Percutaneous Coronary Revascularization,Coronary Intervention, Percutaneous,Coronary Interventions, Percutaneous,Coronary Revascularization, Percutaneous,Coronary Revascularizations, Percutaneous,Intervention, Percutaneous Coronary,Interventions, Percutaneous Coronary,Percutaneous Coronary Interventions,Percutaneous Coronary Revascularizations,Revascularization, Percutaneous Coronary,Revascularizations, Percutaneous Coronary

Related Publications

H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Prognosis of asymptomatic coronary artery disease after percutaneous coronary intervention.
June 2010, The American journal of cardiology,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease.
April 2015, International journal of cardiology,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Long term prognosis of atrial fibrillation in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
August 2017, International journal of cardiology,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Evolving Field of Long-term Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation.
August 2019, The American journal of the medical sciences,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Prognosis of anemic patients with atrial fibrillation undergoing percutaneous coronary intervention.
March 2024, International journal of cardiology,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Long-term prevention of atrial fibrillation after coronary artery surgery.
June 1997, Panminerva medica,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations.
September 1987, The Journal of thoracic and cardiovascular surgery,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Prognostic Nutritional Index as a Novel Predictor of Long-Term Prognosis in Patients with Coronary Artery Disease After Percutaneous Coronary Intervention.
January 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review.
September 2017, International journal of cardiology,
H H Wang, and J J Xu, and Y Song, and X F Tang, and P Jiang, and R Liu, and X Y Zhao, and Z Gao, and Y Zhang, and L Song, and L J Gao, and J Chen, and Y J Yang, and R L Gao, and S B Qiao, and B Xu, and J Q Yuan
Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
August 2019, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!